TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Total assets 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) total assets at each fiscal year-end, per SEC filings.
$40.7BFY2025 · since FY2016: $93.1B → $40.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $40.7B | +3.6% |
| FY2024 | $39.3B | -9.6% |
| FY2023 | $43.5B | -1.2% |
| FY2022 | $44.0B | -7.7% |
| FY2021 | $47.7B | -5.9% |
| FY2020 | $50.6B | -11.9% |
| FY2019 | $57.5B | -5.3% |
| FY2018 | $60.7B | -14.1% |
| FY2017 | $70.6B | -24.1% |
| FY2016 | $93.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TEVA financial trends
TEVA RevenueTEVA Net incomeTEVA Net marginTEVA Gross profitTEVA Gross marginTEVA Operating incomeTEVA Operating marginTEVA Operating cash flowTEVA Free cash flowTEVA Capital expendituresTEVA Return on equityTEVA Stock buybacksTEVA Dividends paidTEVA Total liabilitiesTEVA Shareholders’ equityTEVA overview →